A Study of BYL719 in Adult Patients With Advanced Solid Malignancies
Status:
Completed
Trial end date:
2015-11-25
Target enrollment:
Participant gender:
Summary
In this study, BYL719 will be administered to adult patients with advanced solid tumors whose
disease has progressed despite standard therapy or for whom no standard therapy exists. The
trial will investigate the safety and tolerability and determine the MTD of BYL719 in
Japanese patients.